- The Washington Times - Friday, March 10, 2017

President Trump said Friday night he will nominate Scott Gottlieb, a former deputy commissioner of the Food and Drug Administration, to lead the agency.

Mr. Gottlieb, a physician, is a partner in the venture capital firm New Enterprise Associates and serves as an adviser to several pharmaceutical companies.

If confirmed by the Senate, he would lead oversight of the federal agency that decides whether to approve new drugs, as well as regulates food safety and tobacco products.

In 2005, he was appointed as the FDA’s deputy commissioner for medical and scientific affairs in the George W. Bush administration.



Click to Read More

Click to Hide